Home›Search›PharmacoEconomics - Open

PharmacoEconomics - Open

Springer International Publishing · Switzerland · Est. 2011

ISSN2509-4262eISSN2509-4254

SJR Q2✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.86

H-Indexi

SNIPi

0.827

Total Worksi

642

Total Citationsi

6,521

2yr Mean Citednessi

2.39

Open Impact Factor alternative

Aims & Scope

Subject areas: Economics; Health Care Sciences & Services; Health Policy & Services; Pharmacology & Pharmacy; Health Policy; Pharmacology; Pharmacology (medical).

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published2011

Annual Volume~ 81 articles / year

StatusActive (last: 2026)

Total Publications642

Publisher OrgAdis, Springer Healthcare

OA Since2016

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Springer International Publishing

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2509-4262 / 2509-4254

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.2k

2019

817

2020

2021

741

2022

584

2023

462

2024

136

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health PolicyQ2

PharmacologyQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

EconomicsHealth Care Sciences & ServicesHealth Policy & ServicesPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Health Policy

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of CancerPharmaceutical Economics and PolicyEconomic and Environmental ValuationHealthcare Policy and ManagementMultiple Sclerosis Research StudiesMedication Adherence and ComplianceCancer Immunotherapy and BiomarkersHealthcare Systems and ReformsLung Cancer Treatments and Mutations

Frequently asked questions about PharmacoEconomics - Open

Is PharmacoEconomics - Open a predatory journal?

PubScope has no integrity flags on record for PharmacoEconomics - Open: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of PharmacoEconomics - Open?

PharmacoEconomics - Open is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.39.

Is PharmacoEconomics - Open indexed in Scopus and Web of Science?

PharmacoEconomics - Open is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of PharmacoEconomics - Open?